A major advisory firm just built a new global platform through acquisition, and the stock did not move; an infrastructure and defense name trades at half its GF Value with a trillion-dollar policy tailwind behind it; and a fertilizer producer sits at a real discount with a buy rating attached. You can get ahead of all three before sentiment catches up to the news.

Software

Adobe Inc. (NASDAQ: ADBE), the creative and marketing software company, trades around $218.80 against a $331.65 consensus target, about 34% below where analysts think the stock can go.

Q2 revenue hit a record $6.62 billion, up 13%, while non-GAAP EPS came in at $5.96. The company also raised full-year revenue guidance to $26.5 billion to $26.6 billion and non-GAAP EPS guidance to $24.35 to $24.45.

The market is not ignoring the numbers. It is reacting to the story around them. Adobe’s CFO exit adds another leadership question at a time when investors are already debating whether AI helps the company defend its moat or slowly chips away at it. That is why a record quarter still turned into a selloff.

At this price, you get a profitable software leader valued as if the market still needs proof that the AI transition is a friend, not a threat.

Record Quarter Keeps the Bear Case From Getting Too Comfortable

A 13% revenue gain, $5.96 in non-GAAP EPS, and AI-first ARR above $500 million are not signs of a broken business. Adobe still has pricing power, cash generation, and enterprise demand working in its favor.

Consensus Gap Makes the Selloff Worth Watching

A $331.65 target is not a promise, but the gap is wide enough to matter after a quarter like this. If AI adoption continues to lift revenue rather than replace Adobe’s core tools, the market may be punishing leadership uncertainty more than fundamentals.

Education

New Oriental Education & Technology Group Inc. (NYSE: EDU), the China-based education and test-prep company, trades around $45.20 against a fresh $65 target, roughly 30% below that level.

The upgrade is tied directly to valuation, with the stock trading at about 3x calendar 2026 earnings excluding net cash. That is an unusual setup for a profitable education business with real cash behind it.

The cash position is the point. New Oriental had about $5.4 billion in net cash as of fiscal Q3 2026, equal to roughly 75% of its market value. Q3 revenue also rose 19.8% to $1.42 billion, operating income increased 44.8% to $180.3 million, and net income rose 45.3% to $126.8 million.

You get a profitable education platform priced like investors still want a China-risk discount before giving the cash and earnings power full credit.

Net Cash Makes the Multiple Look Hard to Ignore

A stock at about 3x cash-adjusted earnings is not being valued like a normal growth company. New Oriental’s balance sheet gives the thesis more protection than the headline multiple alone suggests.

Shareholder Returns Add Weight to the Case

The company has already tied fiscal 2026 returns to dividends and buybacks, including a $1.20 per ADS dividend and a $300 million repurchase program.. That does not remove policy risk, but it does show cash is not just sitting there. Some of it is being sent back, while the market still prices the stock as if trust has to be earned slowly.

Real Estate Services 

Cushman & Wakefield plc (NYSE: CWK), the commercial real estate services firm, trades around $13.21 against a fair value narrative of $18.38, a 28% discount. Q1 revenue rose 11% to $2.5 billion, adjusted EBITDA increased 16% to $111.3 million, and adjusted EPS climbed to $0.15.

That is not a broken commercial real estate story. It is a cyclical business that is starting to show stronger operating momentum.

The market still has reasons to stay cautious. Commercial real estate recovery is uneven, financing conditions remain tight, and Cushman & Wakefield still reported a GAAP net loss after non-cash items and other headwinds.

But leasing revenue grew 19%, capital markets revenue rose 15%, and adjusted net income rose 69% to $34.7 million. . The ugly parts are real, but they are no longer the whole story.

A 28% fair value gap with leasing and capital markets improving is the kind of setup that can stop looking ignored once the recovery becomes harder to dismiss.

Leasing Recovery Gives the Turnaround More Weight

A 19% gain in leasing revenue matters because transaction activity is where sentiment usually turns first. If clients keep moving from caution to decision-making, Cushman gets a cleaner path to operating leverage.

Fair Value Gap Keeps the Case Interesting

A fair value narrative is not a guaranteed target. But when you get improving leasing, stronger capital markets activity, and a stock still below estimated value, the market may be leaving room for a recovery it does not fully trust yet.

Prestige Consumer Healthcare (NYSE: PBH) makes over-the-counter health brands including Clear Eyes, Dramamine, Monistat, and Summer's Eve, and the stock has been hammered down 37% over the past year to around $49 against a GF Value of $67.85, a 27.6% discount, with the most-followed fair value narrative pegging it at $78.50 for a 66.55% intrinsic discount.

Management guided fiscal 2026 revenue down slightly to $1.10 to $1.115 billion, but the brand portfolio remains category-leading in niche consumer health segments with real moat protection. A 6.24% share buyback completed for $207 million shows management thinks the stock is cheap too.

The risk is that emerging large players like Haleon and Kenvue use their scale to displace some of Prestige's smaller brands faster than the buyback can offset the pressure.

Metropolitan Bank Holding (NYSE: MCB) is a New York commercial bank trading at around $94 against a future cash flow fair value estimate of $157.18, putting it significantly below that model, with a P/CF ratio of 6.52 against an industry average of 10.10.

Q1 2026 net interest income rose to $85.91 million with net income of $31.43 million, both growing year over year, and earnings are projected to grow significantly over the next three years. The bank scores a 7 out of 10 valuation rating, which is rare for a name this cheap on a cash flow basis.

The risk is that recent insider selling and board changes signal something the cash flow model is not yet capturing about near-term credit quality.

Sylvamo (NYSE: SLVM), the world's largest producer of uncoated freesheet paper for education, communication, and printing, just hit a fresh 52-week low of $36.98 against a 1-year analyst target of $63.33, a gap of more than 70%.

The forward PE sits between 9.86 and 14.86, depending on the quarter; the dividend yield runs between 3.5% and 4.58%, and the company has raised its dividend for four consecutive years. Q1 2026 EPS of negative $0.08 beat the negative $0.24 consensus by a wide margin, showing the business is executing better than the market is pricing in.

The risk is that European paper demand continues declining structurally faster than cost discipline and pricing power can offset, keeping the stock at trough multiples longer than the dividend growth track record would suggest.

That's our coverage for today; thanks for reading! Reply to this email with feedback or any [blank] stocks you want me to check out.

Best Regards,
—Noah Zelvis
Undervalued Edge